NASDAQ
BridgeBio Pharma, Inc. (BBIO) has a current ratio of 2.62x as of Monday, May 25, 2026. This represents a 45.16% decrease compared to its 12-month average of 4.77x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.